Peters Paul J, Sullivan W Matthew, Duenas-Decamp Maria J, Bhattacharya Jayanta, Ankghuambom Chiambah, Brown Richard, Luzuriaga Katherine, Bell Jeanne, Simmonds Peter, Ball Jonathan, Clapham Paul R
Center for AIDS Research, Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation St., Biotech II Suite 315, Worcester, MA 01605, USA.
J Virol. 2006 Jul;80(13):6324-32. doi: 10.1128/JVI.02328-05.
Human immunodeficiency virus type 1 (HIV-1) R5 isolates that predominantly use CCR5 as a coreceptor are frequently described as macrophage tropic. Here, we compare macrophage tropism conferred by HIV-1 R5 envelopes that were derived directly by PCR from patient tissue. This approach avoids potentially selective culture protocols used in virus isolation. Envelopes were amplified (i) from blood and semen of adult patients and (ii) from plasma of pediatric patients. The phenotypes of these envelopes were compared to those conferred by an extended panel of envelopes derived from brain and lymph node that we reported previously. Our results show that R5 envelopes vary by up to 1,000-fold in their capacity to confer infection of primary macrophages. Highly macrophage-tropic envelopes were predominate in brain but were infrequent in semen, blood, and lymph node samples. We also confirmed that the presence of N283 in the C2 CD4 binding site of gp120 is associated with HIV-1 envelopes from the brain but absent from macrophage-tropic envelopes amplified from blood and semen. Finally, we compared infection of macrophages, CD4(+) T cells, and peripheral blood mononuclear cells (PBMCs) conferred by macrophage-tropic and non-macrophage-tropic envelopes in the context of full-length replication competent viral clones. Non-macrophage-tropic envelopes conferred low-level infection of macrophages yet infected CD4(+) T cells and PBMCs as efficiently as highly macrophage-tropic brain envelopes. The lack of macrophage tropism for the majority of the envelopes amplified from lymph node, blood, and semen is striking and contrasts with the current consensus that R5 primary isolates are generally macrophage tropic. The extensive variation in R5 tropism reported here is likely to have an important impact on pathogenesis and on the capacity of HIV-1 to transmit.
主要利用CCR5作为共受体的1型人类免疫缺陷病毒(HIV-1)R5分离株通常被描述为嗜巨噬细胞型。在此,我们比较了通过聚合酶链反应(PCR)直接从患者组织获得的HIV-1 R5包膜糖蛋白所赋予的嗜巨噬细胞性。这种方法避免了病毒分离中可能存在的选择性培养方案。包膜糖蛋白从(i)成年患者的血液和精液以及(ii)儿科患者的血浆中扩增得到。将这些包膜糖蛋白的表型与我们之前报道的一组来自脑和淋巴结的包膜糖蛋白的表型进行比较。我们的结果表明,R5包膜糖蛋白在赋予原代巨噬细胞感染能力方面的差异高达1000倍。高度嗜巨噬细胞的包膜糖蛋白在脑中占主导,但在精液、血液和淋巴结样本中很少见。我们还证实了gp120的C2 CD4结合位点中N283的存在与来自脑的HIV-1包膜糖蛋白相关,但从血液和精液中扩增得到的嗜巨噬细胞包膜糖蛋白中不存在。最后,我们在全长具有复制能力的病毒克隆背景下,比较了嗜巨噬细胞型和非嗜巨噬细胞型包膜糖蛋白对巨噬细胞、CD4(+) T细胞和外周血单核细胞(PBMC)的感染情况。非嗜巨噬细胞型包膜糖蛋白对巨噬细胞的感染水平较低,但对CD4(+) T细胞和PBMCs的感染效率与高度嗜巨噬细胞的脑包膜糖蛋白一样高有效。从淋巴结、血液和精液中扩增得到的大多数包膜糖蛋白缺乏嗜巨噬细胞性,这一点很显著,与目前认为R5原代分离株通常为嗜巨噬细胞型的共识形成对比。本文报道的R5嗜性的广泛差异可能对发病机制以及HIV-1的传播能力产生重要影响。